|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.380 USD | +6.53% |
|
+3.26% | -6.76% |
Company Valuation: Unicycive Therapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 30.84 | 8.148 | 30.16 | 82.44 | 124 | 147.4 | - | - |
| Change | - | -73.58% | 270.11% | 173.36% | 50.43% | 18.85% | - | - |
| Enterprise Value (EV) | 30.84 | 8.148 | 30.16 | 82.44 | 124 | 147.4 | 147.4 | 147.4 |
| Change | - | -73.58% | 270.11% | 173.36% | 50.43% | 18.85% | 0% | 0% |
| P/E | -2.4x | -0.45x | -0.68x | -1.42x | -3.46x | -3.8x | 1.05x | 0.56x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | -0x | -0.1x | 0x | 0x | 0.2x | -0x | 0x |
| Capitalization / Revenue | - | 8.57x | 44.7x | - | - | 38.7x | 0.51x | 0.26x |
| EV / Revenue | - | 0x | 0x | - | - | 38.7x | 0.51x | 0.26x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -3.7x | 0.71x | 0.38x |
| EV / FCF | -0x | - | -0x | -0x | -0x | -5.46x | -4.05x | 0.88x |
| FCF Yield | -18.8% | - | -60.7% | -34.8% | -25.3% | -18.3% | -24.7% | 113% |
| Dividend per Share 2 | - | - | - | - | - | - | 2.3 | 5.8 |
| Rate of return | - | - | - | - | - | - | 42.8% | 108% |
| EPS 2 | -8.6 | -12 | -12.8 | -5.6 | -1.67 | -1.415 | 5.146 | 9.648 |
| Distribution rate | - | - | - | - | - | - | 44.7% | 60.1% |
| Net sales 1 | - | 0.951 | 0.675 | - | - | 3.804 | 288.4 | 566.6 |
| EBITDA | - | - | - | - | - | - | - | - |
| EBIT 1 | -8.977 | -18.05 | -20.77 | -32.12 | -29.52 | -39.78 | 208.2 | 386.1 |
| Net income 1 | -10.02 | -18.06 | -31.41 | -37.82 | -26.56 | -40.34 | 186.2 | 366.7 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 20.600 | 5.400 | 8.677 | 7.942 | 5.770 | 5.380 | 5.380 | 5.380 |
| Nbr of stocks (in thousands) | 1,497 | 1,509 | 3,475 | 10,380 | 21,491 | 27,393 | - | - |
| Announcement Date | 31/03/22 | 31/03/23 | 28/03/24 | 31/03/25 | 30/03/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.8x | - | - | - | 147M | |
| 32.22x | 8.13x | 25.24x | 0.05% | 53.83B | |
| 19.5x | 6.01x | 13.15x | 1.63% | 52.1B | |
| -42.48x | 13.5x | -39.59x | -.--% | 23.48B | |
| -18.22x | 4.32x | -7.57x | -.--% | 23.13B | |
| 24.24x | 4.75x | 12.54x | -.--% | 19.36B | |
| 24.39x | 4.78x | 15.56x | -.--% | 17.56B | |
| 45.88x | 18.59x | 47.88x | 0.08% | 15.2B | |
| -505.73x | 35.47x | -1462.84x | -.--% | 14.83B | |
| 17.57x | 5.11x | 11.88x | -.--% | 14.06B | |
| Average | -40.64x | 11.19x | -153.75x | 0.2% | 23.37B | |
| Weighted average by Cap. | -18.51x | 9.52x | -82.82x | 0.38% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- UNCY Stock
- Valuation Unicycive Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
